segmental vitiligo
Conditions
Interventions
Segmental Vitiligo Patients:Nome
Healthy control group:None
Sponsors
First Affiliated Hospital of Kunming Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion Criteria: 1. Patients voluntarily participated in the study and signed the informed consent form; 2. Patients who clinically meet the diagnostic criteria for segmental vitiligo, regardless of age or gender; 3. No local or systemic laser therapy, phototherapy, immunosuppressant, or steroid treatment received in the past month; 4. Able to provide detailed past treatment records, including the course of vitiligo and treatment history.
Exclusion criteria
Exclusion criteria: 1.Exclusion Criteria: 1. Those who do not meet the inclusion criteria or are deemed unsuitable for participation in this trial by a dermatologist; 2. Patients with a history of systemic neurological diseases or peripheral neuropathy; 3. Patients with severe cardiovascular diseases or endocrine disorders (such as diabetes mellitus, thyroid dysfunction, etc.); 4. Patients currently using medications that may affect neurological or sympathetic nervous function, such as sedatives, antidepressants, antipsychotics, beta-blockers, etc. 5. Patients with recent trauma, infection, or other conditions that may affect local nerve or blood flow function; 6. Patients with allergies to skin tests or intolerance to related dermatological examinations; 7. Pregnant or lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Current Perception Threshold;Skin Conductance Level;TIVI (Tissue Viability Index); | — |
Countries
China
Contacts
Public ContactDongjie Sun
First Affiliated Hospital of Kunming Medical University
Outcome results
None listed